273 related articles for article (PubMed ID: 30754665)
1. Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in
Cerni S; Shafer D; To K; Venketaraman V
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30754665
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the mTOR Pathway for Tuberculosis Treatment.
Singh P; Subbian S
Front Microbiol; 2018; 9():70. PubMed ID: 29441052
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial Effects of Everolimus in a Human Granuloma Model.
Ashley D; Hernandez J; Cao R; To K; Yegiazaryan A; Abrahem R; Nguyen T; Owens J; Lambros M; Subbian S; Venketaraman V
J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32610643
[No Abstract] [Full Text] [Related]
4. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis.
Chai Q; Wang L; Liu CH; Ge B
Cell Mol Immunol; 2020 Sep; 17(9):901-913. PubMed ID: 32728204
[TBL] [Abstract][Full Text] [Related]
5. Autophagy: A new strategy for host-directed therapy of tuberculosis.
Paik S; Kim JK; Chung C; Jo EK
Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
7. Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation.
Ahmed S; Raqib R; Guðmundsson GH; Bergman P; Agerberth B; Rekha RS
Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31936156
[TBL] [Abstract][Full Text] [Related]
8. The Macrophage Response to
Maphasa RE; Meyer M; Dube A
Front Cell Infect Microbiol; 2020; 10():618414. PubMed ID: 33628745
[TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with
Zhang Q; Sun J; Wang Y; He W; Wang L; Zheng Y; Wu J; Zhang Y; Jiang X
Front Microbiol; 2017; 8():2142. PubMed ID: 29163427
[TBL] [Abstract][Full Text] [Related]
10. Effects of Everolimus in Modulating the Host Immune Responses against
Raien A; Davis S; Zhang M; Zitser D; Lin M; Pitcher G; Bhalodia K; Subbian S; Venketaraman V
Cells; 2023 Nov; 12(22):. PubMed ID: 37998388
[TBL] [Abstract][Full Text] [Related]
11. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
Lee HJ; Ko HJ; Kim SH; Jung YJ
PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
[TBL] [Abstract][Full Text] [Related]
12. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
13. Ibrutinib suppresses intracellular mycobacterium tuberculosis growth by inducing macrophage autophagy.
Hu Y; Wen Z; Liu S; Cai Y; Guo J; Xu Y; Lin D; Zhu J; Li D; Chen X
J Infect; 2020 Jun; 80(6):e19-e26. PubMed ID: 32171871
[TBL] [Abstract][Full Text] [Related]
14. Host-Pathogen Dialogues in Autophagy, Apoptosis, and Necrosis during Mycobacterial Infection.
Kim JK; Silwal P; Jo EK
Immune Netw; 2020 Oct; 20(5):e37. PubMed ID: 33163245
[No Abstract] [Full Text] [Related]
15. Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection.
Silwal P; Paik S; Kim JK; Yoshimori T; Jo EK
Front Cell Infect Microbiol; 2021; 11():633360. PubMed ID: 33828998
[No Abstract] [Full Text] [Related]
16. MicroRNA-27a controls the intracellular survival of Mycobacterium tuberculosis by regulating calcium-associated autophagy.
Liu F; Chen J; Wang P; Li H; Zhou Y; Liu H; Liu Z; Zheng R; Wang L; Yang H; Cui Z; Wang F; Huang X; Wang J; Sha W; Xiao H; Ge B
Nat Commun; 2018 Oct; 9(1):4295. PubMed ID: 30327467
[TBL] [Abstract][Full Text] [Related]
17. Autophagy induction targeting mTORC1 enhances Mycobacterium tuberculosis replication in HIV co-infected human macrophages.
Andersson AM; Andersson B; Lorell C; Raffetseder J; Larsson M; Blomgran R
Sci Rep; 2016 Jun; 6():28171. PubMed ID: 27302320
[TBL] [Abstract][Full Text] [Related]
18. Harnessing host-pathogen interactions for innovative drug discovery and host-directed therapeutics to tackle tuberculosis.
Saini S; Gangwar A; Sharma R
Microbiol Res; 2023 Oct; 275():127466. PubMed ID: 37531813
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Everolimus Activity against
Bianco DM; De Maio F; Santarelli G; Palucci I; Salustri A; Bianchetti G; Maulucci G; Citterio F; Sanguinetti M; Tamburrini E; Sali M; Delogu G
Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671372
[TBL] [Abstract][Full Text] [Related]
20. Protein Kinase R Restricts the Intracellular Survival of
Smyth R; Berton S; Rajabalee N; Chan T; Sun J
Front Microbiol; 2020; 11():613963. PubMed ID: 33552025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
